Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations

BACKGROUND: Hybrid controlled trials with real-world data (RWD), where the control arm is composed of both trial and real-world patients, could facilitate research when the feasibility of randomized controlled trials (RCTs) is challenging and single-arm trials would provide insufficient information....

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, W. Katherine, Segal, Brian D., Curtis, Melissa D., Baxi, Shrujal S., Capra, William B., Garrett-Mayer, Elizabeth, Hobbs, Brian P., Hong, David S., Hubbard, Rebecca A., Zhu, Jiawen, Sarkar, Somnath, Samant, Meghna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519429/
https://www.ncbi.nlm.nih.gov/pubmed/36186544
http://dx.doi.org/10.1016/j.conctc.2022.101000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519429/
https://www.ncbi.nlm.nih.gov/pubmed/36186544
http://dx.doi.org/10.1016/j.conctc.2022.101000

Ejemplares similares